MENU
+Compare
LUCD
Stock ticker: NASDAQ
AS OF
Dec 24 closing price
Price
$1.11
Change
+$0.01 (+0.91%)
Capitalization
145.52M

LUCD Lucid Diagnostics Forecast, Technical & Fundamental Analysis

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma... Show more

LUCD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for LUCD with price predictions
Dec 24, 2025

LUCD in upward trend: 10-day moving average moved above 50-day moving average on December 22, 2025

The 10-day moving average for LUCD crossed bullishly above the 50-day moving average on December 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for LUCD just turned positive on December 04, 2025. Looking at past instances where LUCD's MACD turned positive, the stock continued to rise in of 36 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LUCD advanced for three days, in of 213 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 24, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on LUCD as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

LUCD moved below its 50-day moving average on December 23, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LUCD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LUCD broke above its upper Bollinger Band on December 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for LUCD entered a downward trend on December 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LUCD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (63.841). P/E Ratio (0.000) is within average values for comparable stocks, (37.253). LUCD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.634). LUCD has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (21.142) is also within normal values, averaging (36.935).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LUCD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
LUCD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

LUCD is expected to report earnings to fall 8.00% to -9 cents per share on March 30

Lucid Diagnostics LUCD Stock Earnings Reports
Q4'25
Est.
$-0.09
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.03
Q4'24
Missed
by $0.02
The last earnings report on November 12 showed earnings per share of -10 cents, beating the estimate of -10 cents. With 250.72K shares outstanding, the current market capitalization sits at 145.52M.
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
360 Madison Avenue
Phone
+1 917 813-1828
Employees
70
Web
https://www.luciddx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QNCCF3.670.35
+10.65%
Quantum eMotion Corp.
WTKWY104.320.15
+0.14%
Wolters Kluwer N.V.
NWSZF1.00N/A
N/A
CTF Services Limited
EXCE18.10N/A
N/A
EXCO Resources, Inc.
VRTK2.05N/A
N/A
Vartech Systems Inc.

LUCD and Stocks

Correlation & Price change

A.I.dvisor tells us that LUCD and NOTV have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LUCD and NOTV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LUCD
1D Price
Change %
LUCD100%
-2.65%
NOTV - LUCD
32%
Poorly correlated
-4.57%
FEMY - LUCD
30%
Poorly correlated
+0.52%
NXL - LUCD
29%
Poorly correlated
-6.52%
CRL - LUCD
27%
Poorly correlated
-0.07%
INGN - LUCD
26%
Poorly correlated
-1.04%
More

Groups containing LUCD

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LUCD
1D Price
Change %
LUCD100%
-2.65%
Medical/Nursing Services
industry (213 stocks)
24%
Poorly correlated
+0.17%
Health Services
industry (404 stocks)
2%
Poorly correlated
+0.20%